Our data clearly document that loss of NFAT2 expression is sufficient to induce lymphoma transformation in the TCL1 mouse model and suggest that NFAT2 is also a relevant factor in the pathogenesis of Richter’s syndrome in human CLL patients. This evidence concerns the gene NFATC1 and B-cell chronic lymphocytic leukemia.